All Posts

Pulse oximeter development often requires dependable performance feedback well before a formal regulatory accuracy study is initiated. During this stage, teams iterate on sensor hardware, algorithms, calibration curves, and signal-quality controls. To make meaningful progress, they need a repeatable way to compare performance across prototypes and study sessions.  A transfer standard helps fill that role. It is an intermediary pulse oximeter system with calibration traceable

What Is Hypoxia and Why It Matters in Device Validation   Hypoxia refers to a reduction in oxygen availability at the tissue level. In clinical research and pulse oximetry validation, the focus is arterial oxygen saturation (SaO₂) or the percentage of hemoglobin molecules carrying oxygen in the blood.  The Parameters Research Laboratory (PRL) Hypoxia Lab in Broomfield, Colorado is designed for pulse oximetry validation. By safely simulating altitude and lowering oxygen levels

Understanding the Fundamentals Behind Accurate SpO₂ Measurement   Pulse oximetry is deceptively simple on the surface: shine light into tissue, measure what comes back, and estimate oxygen saturation. In practice, pulse oximeter design involves a series of tightly coupled optical, physiological, and signal-processing decisions that directly influence performance, inclusivity, and regulatory readiness.  For device developers, understanding these fundamentals early can reduce d

As wearable and software-enabled technologies increasingly estimate physiological parameters such as oxygen saturation, blood pressure, and heart rate variability, regulatory classification has become a critical design consideration. The FDA’s General Wellness: Policy for Low Risk Devices clarifies when products using non-invasive sensing—such as optical sensing—may be considered general wellness products rather than regulated medical devices.  For developers conducting a cl

Physiological monitoring in wearables has expanded rapidly, but blood pressure and heart-rate sensing now represent two of the most scrutinized technologies for regulators. As devices transition from lifestyle tools to clinical-grade solutions, development teams must demonstrate performance that meets rigorous standards such as ISO 81060-2 , ISO 81060-7, ISO 81060-3 and ISO 14155 .  Parameters Research Laboratory (PRL) supports developers navigating this shift by delivering

Pulse oximetry is broadly adopted across clinical care and wearable technologies. Standardized terminology shared by engineering, clinical research, and regulatory teams promotes aligned protocols, reproducible analyses, and more efficient FDA and CE reviews.   This glossary provides clear definitions of core pulse oximetry terms commonly encountered during pulse oximetry testing, controlled desaturation studies following ISO 80601-2-61 , and regulatory-grade CRO engagements.

A Familiar Framework with Important Regulatory Implications   In January 2026, the FDA released a draft guidance titled “ Cuffless Non-Invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation .” The document outlines FDA’s current recommendations on how cuffless blood pressure (BP) devices—both intermittent and continuous—should be clinically evaluated to support premarket submissions.  For developers already working in this space, the guidance

Dyshemoglobins and Pulse Oximetry: How COHb and MetHb Influence Measurement Accuracy   Pulse oximetry has become central to physiological monitoring across wearables, medical devices, and clinical research studies. Yet even the most advanced sensor architectures face fundamental challenges when hemoglobin exists in altered forms—known as dyshemoglobins . Carboxyhemoglobin (COHb) and methemoglobin (MetHb) change light absorption in ways that directly influence SpO₂ readings an

When planning a clinical research study intended to support an FDA submission , sponsors often encounter terms such as multi-site, multi-investigator , and single-site, multiple-location . While these models may appear operationally similar, they differ in oversight structure, execution, and how evidence is evaluated by the FDA—particularly for cuffless blood pressure devices . Understanding these distinctions is essential for aligning trial design with FDA expectations and w

Why ISO 81060-2 Matters for Accurate Blood Pressure Monitoring   Non-invasive blood pressure devices must demonstrate dependable performance before developers can advance toward FDA or CE mark submissions. ISO 81060-2  “Non-invasive sphygmomanometers — Part 2: Clinical investigation of intermittent automated measurement type ” sets a clear bar for clinical validation—defining study methods, reference comparisons, subject distribution, cuff/arm-size coverage, and prespecified

Accurate oxygen saturation measurement is foundational for modern physiological monitoring, especially for developers of pulse oximeters, wearables, and multiparameter platforms. Yet many devices fail to achieve regulatory expectations because their performance is never tested across the full range of oxygen saturation levels humans experience.  Controlled desaturation studies fill this gap, ensuring claims reflect real-world performance. These studies intentionally and safel

Transparent clinical operations have become a defining differentiator for high-performing contract research organizations. Yet many medical device and wearable developers still encounter opaque decision-making, limited protocol visibility, and communication gaps that slow execution and create unnecessary regulatory friction. The result is predictable: CRO risk mitigation becomes reactive instead of proactive , and promising technologies reach the FDA or CE mark later than the

Engineering leaders developing physiological monitoring devices often encounter references to “arterial line measurements” in validation standards and technical literature. Although arterial lines are invasive and placed in clinical environments, the data they generate is central to how the industry defines accuracy for non-invasive technologies.  This article explains what an arterial line is, why its measurements are considered a benchmark, and how arterial line data is use

Engineering Reliability: What CTOs Need to Know About Regulatory-Grade Physiological Monitoring Validation   CTOs in medical-device startups face an engineering challenge that extends far beyond hardware and firmware. The success of a physiological monitoring product—whether a pulse oximeter, blood pressure monitor, or wearable sensing platform—depends on rigorous clinical research studies capable of supporting FDA and CE mark submissions. The gap between early engineering va

How PRL Ensures Data Integrity in Physiological Monitoring Research   For CTOs and technical leaders in MedTech, data integrity is not a paperwork detail—it is the backbone of regulator-ready evidence. Whether your device requires pulse oximetry testing during controlled desaturation in a hypoxia lab, multi-parameter wearables validation, or multi-site clinical research studies, every data point must be defensible. ALCOA+ provides the industry-standard framework for achieving

Introduction: Inclusion Begins with Ethical Engagement   In clinical research, the term “vulnerable populations” describes individuals who may be at risk of coercion, manipulation, or harm due to limited autonomy, health literacy, socioeconomic disadvantage, or institutional dependence. Examples include individuals with cognitive limitations, students or employees under authority, people with limited language proficiency, or those experiencing social or economic marginalizat

Introduction: Verification Defines Trust in Pulse Oximetry Pulse oximeters are among the most widely used physiological monitoring devices—found in hospitals worldwide. Yet, behind every reliable SpO₂ reading lies a complex scientific process: verification against reference standards . Pulse oximeter verification studies (or pivotal studies) confirm how closely a device’s functional oxygen saturation (SpO₂) values align with the true arterial oxygen saturation (SaO₂), measure

Introduction: The Foundation of Reliable Oxygenation Research   Controlled desaturation studies are central to validating  pulse oximeters . These studies, performed in specialized hypoxia laboratories  such as PRL, safely lower arterial oxygen saturation (SaO₂) to predefined plateaus, typically from %100 to 70% SaO₂, generating reference data used to calibrate or verify pulse oximeters.  At the core of this process lies one indispensable element: accurate blood gas analysis

Introduction: Why Respiratory Rate Matters in Physiological Monitoring   Respiratory rate (RR) is a vital indicator of physiological stability—often the first parameter to shift in response to metabolic stress, infection, or hypoxia. Yet, continuous and unobtrusive respiratory monitoring remains challenging outside of controlled environments.  With the rise of wearable and optical sensing technologies, electrocardiography (ECG) and photoplethysmography (PPG) have emerged as

Introduction: The Importance of Clarity in Blood Pressure Device and Software Classification   As wearable technology advances, more devices are integrating blood pressure features—from clinical-grade monitors to smartwatches that “notify” users of potential changes. But not all blood pressure devices are created—or regulated—the same.  Understanding the difference between a blood pressure measurement device (FDA product code DXN) and a hypertension machine learning-based no